| P2093 | author name string | Balwan Singh | |
| | Mitzi Nagarkatti | |
| | Robert L Price | |
| | Narendra P Singh | |
| | Prakash S Nagarkatti | |
| | Udai P Singh | |
| P2860 | cites work | Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses | Q24562026 |
| | Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue | Q27342536 |
| | Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 |
| | Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils | Q28571560 |
| | Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. | Q64917143 |
| | Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance | Q71396766 |
| | Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats | Q71993274 |
| | Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice | Q73696473 |
| | Intercellular adhesion molecule-1 expression in dextran sodium sulfate-induced colitis in rats | Q73936208 |
| | Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis | Q77522472 |
| | Expression of B7 costimulatory molecules by cells infiltrating the colon in experimental colitis induced by oral dextran sulfate sodium in the mouse | Q77792705 |
| | Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans | Q80134910 |
| | Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction | Q82878986 |
| | Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium | Q83019190 |
| | Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis | Q83897612 |
| | International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 |
| | Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences | Q29617565 |
| | Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells | Q33388613 |
| | The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease | Q33535863 |
| | Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease | Q33707136 |
| | Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis | Q33714931 |
| | Resveratrol suppresses colitis and colon cancer associated with colitis | Q33785741 |
| | TNBS-colitis | Q33867163 |
| | Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice | Q34122251 |
| | The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat. | Q34504906 |
| | Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content | Q34528907 |
| | Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 |
| | Evolving pathophysiologic models of functional gastrointestinal disorders | Q34676855 |
| | Marihuana as medicine. A plea for reconsideration | Q34722488 |
| | The current future understanding of inflammatory bowel disease | Q35021166 |
| | Prospects for cannabinoids as anti-inflammatory agents | Q35047572 |
| | Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? | Q35451574 |
| | Key role of mast cells and their major secretory products in inflammatory bowel disease | Q35648042 |
| | CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. | Q35781582 |
| | Antibodies to interleukin 12 abrogate established experimental colitis in mice | Q36365464 |
| | CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition | Q36732325 |
| | T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade | Q37100252 |
| | The endogenous cannabinoid system protects against colonic inflammation | Q37370275 |
| | The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis | Q39283731 |
| | The immunologic basis of inflammatory bowel disease | Q39460849 |
| | Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment | Q39780145 |
| | Differential roles of CB1 and CB2 cannabinoid receptors in mast cells | Q40649554 |
| | Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis | Q41155333 |
| | Neuro-immune pathobiology of infectious enteric disease. | Q41506204 |
| | Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease | Q41858578 |
| | The jejunal secretion of histamine is increased in active Crohn's disease | Q41933777 |
| | A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes | Q42039464 |
| | Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease | Q42501267 |
| | Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis | Q43130152 |
| | Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells | Q43995349 |
| | Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation | Q44904050 |
| | Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. | Q44922532 |
| | The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. | Q44929021 |
| | Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors | Q46584481 |
| | Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation | Q46887706 |
| | Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors | Q47400210 |
| | Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. | Q51037509 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| | cannabinoids | Q422936 |
| | colitis | Q2453464 |
| | apoptotic process | Q14599311 |
| | CNR2 | Q17907844 |
| P304 | page(s) | 256-267 | |
| P577 | publication date | 2011-11-18 | |
| P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
| P1476 | title | Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis | |
| P478 | volume | 258 | |